Reversing pathological cell states: the road less travelled can extend the therapeutic horizon
- PMID: 37263821
- PMCID: PMC10593090
- DOI: 10.1016/j.tcb.2023.04.004
Reversing pathological cell states: the road less travelled can extend the therapeutic horizon
Abstract
Acquisition of omics data advances at a formidable pace. Yet, our ability to utilize these data to control cell phenotypes and design interventions that reverse pathological states lags behind. Here, we posit that cell states are determined by core networks that control cell-wide networks. To steer cell fate decisions, core networks connecting genotype to phenotype must be reconstructed and understood. A recent method, cell state transition assessment and regulation (cSTAR), applies perturbation biology to quantify causal connections and mechanistically models how core networks influence cell phenotypes. cSTAR models are akin to digital cell twins enabling us to purposefully convert pathological states back to physiologically normal states. While this capability has a range of applications, here we discuss reverting oncogenic transformation.
Keywords: cell state transition assessment and regulation method; control of cell state transitions and fate decisions; digital cell twins; omics data.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests Patent application (No. UK2107576.7) related to this work was filed by the authors.
Figures



Similar articles
-
Control of cell state transitions.Nature. 2022 Sep;609(7929):975-985. doi: 10.1038/s41586-022-05194-y. Epub 2022 Sep 14. Nature. 2022. PMID: 36104561 Free PMC article.
-
Gene regulatory network underlying the immortalization of epithelial cells.BMC Syst Biol. 2017 Feb 16;11(1):24. doi: 10.1186/s12918-017-0393-5. BMC Syst Biol. 2017. PMID: 28209158 Free PMC article.
-
Decoding the principle of cell-fate determination for its reverse control.NPJ Syst Biol Appl. 2024 May 6;10(1):47. doi: 10.1038/s41540-024-00372-2. NPJ Syst Biol Appl. 2024. PMID: 38710700 Free PMC article.
-
Functional variomics and network perturbation: connecting genotype to phenotype in cancer.Nat Rev Genet. 2017 Jul;18(7):395-410. doi: 10.1038/nrg.2017.8. Epub 2017 Mar 27. Nat Rev Genet. 2017. PMID: 28344341 Free PMC article. Review.
-
MicroRNAs as modulators of T cell functions in cancer.Cancer Lett. 2018 Aug 28;430:172-178. doi: 10.1016/j.canlet.2018.05.019. Epub 2018 May 22. Cancer Lett. 2018. PMID: 29800683 Review.
Cited by
-
A statistical approach for systematic identification of transition cells from scRNA-seq data.Cell Rep Methods. 2024 Dec 16;4(12):100913. doi: 10.1016/j.crmeth.2024.100913. Epub 2024 Dec 6. Cell Rep Methods. 2024. PMID: 39644902 Free PMC article.
-
miRNAs from Zebrafish Embryo Extracts Inhibit Breast Cancer Invasiveness and Migration by Modulating miR-218-5p/PI3K Pathway.Int J Mol Sci. 2025 Apr 17;26(8):3812. doi: 10.3390/ijms26083812. Int J Mol Sci. 2025. PMID: 40332412 Free PMC article.
-
Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets.Cancers (Basel). 2024 Jun 27;16(13):2354. doi: 10.3390/cancers16132354. Cancers (Basel). 2024. PMID: 39001416 Free PMC article.
-
The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review).Oncol Rep. 2024 Mar;51(3):48. doi: 10.3892/or.2024.8707. Epub 2024 Jan 26. Oncol Rep. 2024. PMID: 38275101 Free PMC article. Review.
-
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease.World J Gastroenterol. 2024 Aug 14;30(30):3541-3547. doi: 10.3748/wjg.v30.i30.3541. World J Gastroenterol. 2024. PMID: 39193573 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources